Trace element levels and cognitive function in rural elderly Chinese.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 2728120)

Published in J Gerontol A Biol Sci Med Sci on June 01, 2008

Authors

Sujuan Gao1, Yinlong Jin, Frederick W Unverzagt, Feng Ma, Kathleen S Hall, Jill R Murrell, Yibin Cheng, Jianzhao Shen, Bo Ying, Rongdi Ji, Janetta Matesan, Chaoke Liang, Hugh C Hendrie

Author Affiliations

1: Department of Medicine, Indiana University School of Medicine, 410 West 10th Street, Suite 3000, Indianapolis, IN 46202, USA. sgao@iupui.edu

Articles citing this

Cadmium, chromium, lead, manganese and nickel concentrations in blood of women in non-polluted areas in Japan, as determined by inductively coupled plasma-sector field-mass spectrometry. Int Arch Occup Environ Health (2010) 0.93

Associations between cadmium exposure and neurocognitive test scores in a cross-sectional study of US adults. Environ Health (2013) 0.82

Zinc intake, status and indices of cognitive function in adults and children: a systematic review and meta-analysis. Eur J Clin Nutr (2015) 0.81

Lead exposure and rate of change in cognitive function in older women. Environ Res (2014) 0.80

Are delta-aminolevulinate dehydratase inhibition and metal concentrations additional factors for the age-related cognitive decline? Int J Environ Res Public Health (2014) 0.79

Blood cadmium levels and Alzheimer's disease mortality risk in older US adults. Environ Health (2016) 0.79

Association between Serum Copper Status and Working Memory in Schoolchildren. Nutrients (2015) 0.78

Cadmium and Alzheimer's disease mortality in U.S. adults: Updated evidence with a urinary biomarker and extended follow-up time. Environ Res (2017) 0.75

A path analysis of multiple neurotoxic chemicals and cognitive functioning in older US adults (NHANES 1999-2002). Environ Health (2017) 0.75

Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases. Int J Mol Sci (2016) 0.75

The association between selenium and lipid levels: a longitudinal study in rural elderly Chinese. Arch Gerontol Geriatr (2014) 0.75

Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients. Oxid Med Cell Longev (2017) 0.75

Articles cited by this

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res (1990) 14.82

Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet (2003) 4.52

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem (1999) 2.30

The set test: a rapid test of mental function in old people. Age Ageing (1972) 2.17

Is exposure to aluminum a risk factor for the development of Alzheimer disease?--No. Arch Neurol (1998) 2.15

Elevation of serum copper levels in Alzheimer's disease. Neurology (2002) 1.93

Calcium hypothesis of Alzheimer's disease and brain aging. Ann N Y Acad Sci (1994) 1.69

Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol (1994) 1.64

Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging (2006) 1.55

Regulation of brain function by exercise. Neurobiol Dis (2003) 1.37

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology (2006) 1.31

Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol (2006) 1.25

Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr (1997) 1.25

Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol (2007) 1.18

Effects of low levels of cadmium and lead on cognitive functioning in children. Arch Environ Health (1982) 1.15

Is exposure to aluminum a risk factor for the development of Alzheimer disease?--Yes. Arch Neurol (1998) 1.11

Improved procedure for eluting DNA from dried blood spots. Clin Chem (1996) 1.08

Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample. Arch Clin Neuropsychol (2006) 1.06

d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Eur J Clin Invest (2002) 1.04

Lead poisoning and brain cell function. Environ Health Perspect (1990) 1.04

Trace element levels in drinking water and cognitive function among elderly Chinese. Am J Epidemiol (2000) 1.00

Neuropsychological effects of occupational exposure to cadmium. J Clin Exp Neuropsychol (1989) 0.85

Possible participation of calcium-regulating factors in senile dementia in elderly female subjects. Gerontology (1990) 0.84

Cadmium concentration in blood in an elderly urban population. Biometals (2000) 0.84

Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology (1996) 0.83

Cadmium in blood in Alzheimer's disease and non-demented subjects: results from a population-based study. Biometals (1994) 0.83

Articles by these authors

Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA (2002) 9.87

Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care (2002) 8.22

Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA (2006) 7.60

Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA (2006) 5.53

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 3.72

Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol (2003) 3.58

Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med (2005) 3.26

Assessment of neurological and behavioural function: the NIH Toolbox. Lancet Neurol (2010) 3.20

Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol (2011) 3.12

Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc (2005) 3.11

Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58

Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant (2007) 2.45

Transitions in care for older adults with and without dementia. J Am Geriatr Soc (2012) 2.38

Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29

Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26

Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol (2010) 2.12

Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc (2006) 2.08

Impact of pain on the outcomes of depression treatment: results from the RESPECT trial. Pain (2007) 2.07

TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord (2009) 1.95

Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol (2003) 1.95

Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variables. Epilepsia (2004) 1.91

Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84

The ACTIVE cognitive training trial and health-related quality of life: protection that lasts for 5 years. J Gerontol A Biol Sci Med Sci (2006) 1.79

MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. J Immunol (2010) 1.77

Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc (2014) 1.74

Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol (2003) 1.70

Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke (2007) 1.69

The effects of the ACTIVE cognitive training trial on clinically relevant declines in health-related quality of life. J Gerontol B Psychol Sci Soc Sci (2006) 1.69

Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord (2009) 1.64

Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol (2011) 1.63

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol (2012) 1.63

Implementing innovative models of dementia care: The Healthy Aging Brain Center. Aging Ment Health (2011) 1.62

NIH toolbox for assessment of neurological and behavioral function. Neurology (2013) 1.52

The effect of speed-of-processing training on depressive symptoms in ACTIVE. J Gerontol A Biol Sci Med Sci (2009) 1.46

Implementing dementia care models in primary care settings: The Aging Brain Care Medical Home. Aging Ment Health (2011) 1.41

Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann Neurol (2006) 1.36

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer (2014) 1.35

Acute care utilization by dementia caregivers within urban primary care practices. J Gen Intern Med (2008) 1.26

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimers Dement (2011) 1.26

Measuring primary care patients' attitudes about dementia screening. Int J Geriatr Psychiatry (2008) 1.24

Errors in self-reports of health services use: impact on alzheimer disease clinical trial designs. Alzheimer Dis Assoc Disord (2015) 1.24

Speed of processing training protects self-rated health in older adults: enduring effects observed in the multi-site ACTIVE randomized controlled trial. Int Psychogeriatr (2009) 1.24

Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med (2002) 1.22

White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol (2008) 1.21

Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol (2006) 1.19

Development and implementation of nonpharmacologic protocols for the management of patients with Alzheimer's disease and their families in a multiracial primary care setting. Gerontologist (2004) 1.18

Risk of mortality for dementia in a developing country: the Yoruba in Nigeria. Int J Geriatr Psychiatry (2002) 1.18

Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol (2007) 1.18

The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain (2007) 1.18

Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis Assoc Disord (2011) 1.17

The ACTIVE cognitive training interventions and the onset of and recovery from suspected clinical depression. J Gerontol B Psychol Sci Soc Sci (2009) 1.17

Does cognitive training improve internal locus of control among older adults? J Gerontol B Psychol Sci Soc Sci (2009) 1.17

Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study. J Am Geriatr Soc (2007) 1.16

Apolipoprotein E and mortality in African-Americans and Yoruba. J Alzheimers Dis (2003) 1.16

The ACTIVE cognitive training trial and predicted medical expenditures. BMC Health Serv Res (2009) 1.14

Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J Gastroenterol (2010) 1.14

Geographical, spatial, and temporal distributions of multiple indoor air pollutants in four Chinese provinces. Environ Sci Technol (2005) 1.12

Accelerated weight loss and incident dementia in an elderly African-American cohort. J Am Geriatr Soc (2010) 1.11

Emotion assessment using the NIH Toolbox. Neurology (2013) 1.10

Who refuses the diagnostic assessment for dementia in primary care? Int J Geriatr Psychiatry (2006) 1.09

Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain (2004) 1.09

Alzheimer's disease, genes, and environment: the value of international studies. Can J Psychiatry (2004) 1.08

Effect of patient perceptions on dementia screening in primary care. J Am Geriatr Soc (2012) 1.07

Diagnosis and assessment of Alzheimer's disease in diverse populations. Alzheimers Dement (2008) 1.07

Mild cognitive dysfunction: an epidemiological perspective with an emphasis on African Americans. J Geriatr Psychiatry Neurol (2007) 1.06

Measuring stigma in children with epilepsy and their parents: instrument development and testing. Epilepsy Behav (2004) 1.06